A novel thermochromic myocardial phantom for radiofrequency ablation and cryoablation.

Carlo Saija^1,2, Sukruth Pradeep Kundur³, Lisa Leung^3,4, Sachin Sabu^3,5, Marco Pinto^5,6, Mark Herridge⁵, Adharvan Gabbeta³, Rashi Chavan³, Nadia Chowdry³, Gregory Gibson⁵, Calum Byrne⁵, Antonia Pontiki³, Richard James Housden³, Pierre Berthet-Rayne^7,8, Jonathan M Behar^3,5, Kawal Rhode³

¹School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK. carlo.saija@kcl.ac.uk.

²Caranx Medical, Nice, France. carlo.saija@kcl.ac.uk.

³School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.

⁴St. George's Hospital, London, UK.

⁵St Thomas Hospital, London, UK.

⁶Biosense Webster, Irvine, USA.

⁷Caranx Medical, Nice, France.

⁸3IA Côte d'Azur, Université Côte D'Azur, Nice, France.

PubMed PMC DOI PDF

Abstract

In the growing field of electrophysiology, cardiac ablation either via heating or freezing target tissues using catheters, induces localised scarring to block or destroy defective electrical pathways in the heart. To test equipment and ablation settings, studies have resorted to ex-vivo and in-vivo models including pigs, dogs, and chickens. The use of animal tissue presents ethical and logistical…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.